Terms and Conditions of Use
Get to know the guidelines for accessing and using the lumivoraquin.sbs automated recommendation platform. Your access to our services signifies agreement with these terms and ongoing compliance.
Last updated December 27, 2025
Acceptance of Terms
By creating an account, accessing our website, or receiving automated recommendations, you agree to comply with these terms and South African law. Please read these terms carefully before using the platform.
Definitions
For clarity, these terms use the following definitions:
- Platform: The lumivoraquin.sbs web portal that processes AI-driven trading recommendations.
- User: Any registered or unregistered individual who makes use of recommendations or features on the platform.
- Content: All information, including recommendations, analytics, and notifications produced or posted on the platform.
- Agreement: This contract governing platform use between the user and lumivoraquin.sbs.
Proper Use of Services
Services are intended for informational support. Users retain full responsibility for decisions and actions. No financial advice, guarantees, or warranties are provided.
Eligibility
Platform access is limited to individuals compliant with South African law and able to enter binding agreements.
Platform is not for minors or prohibited parties.
User Responsibilities
When using lumivoraquin.sbs, you must:
- Provide accurate information for registration and ongoing updates.
- Keep account credentials private and notify us of suspected breaches.
- Use services only for lawful, intended purposes.
- Respect others’ privacy, intellectual property, and local regulations.
Prohibited Activities
Do not misuse the platform. Prohibited actions include:
- Disruption or interference with system security or other users’ activities.
- Unauthorised access or collection of data or platform features.
- Transmission of malware, spam, or harmful digital material.
- Reverse engineering or misuse of platform algorithms or content.
- Infringing on third-party rights or regulations.
Intellectual Property Rights
All Lumivoraquin content, including AI-generated recommendations, software, and site materials, remain lumivoraquin.sbs property. Copying, reusing, or distributing materials without written consent is not allowed.
User-Generated Content
You retain rights to content submitted but grant us a license to use, store, or display such information on the platform.
Your Content Rights:
You may view, update, or delete your submissions, subject to our privacy policy and legal obligations.
Privacy Commitment
Personal information is handled under our Privacy Policy, which forms part of this agreement. Please review the policy for details or updates. View Privacy Policy
Service Disclaimer
Platform outputs are informational and generated automatically.
Caution—No Guarantees:
Our recommendations are not a promise of results or outcomes. Users should independently assess suitability and risk before acting.
Limitation of Liability
Lumivoraquin.com and its affiliates will not be liable for loss, damages, or actions arising from use or reliance on information provided.
Indemnity
You agree to indemnify lumivoraquin.sbs for claims, losses, or costs resulting from rule violations or misuse of services.
Resolving Disputes
Disputes shall be handled using informal and, if needed, formal dispute resolution.
Arbitration
Disputes may be submitted to binding arbitration in South Africa, in accordance with local law and procedures.
Costs and process are outlined separately upon dispute initiation.
Online Dispute Resolution
You may also access local or international ODR mechanisms for digital service disputes.
Find out more here: Find out more here
Governing Law & Jurisdiction
South African law governs all platform terms, disputes, and use.
Termination
Lumivoraquin.com may suspend or terminate platform access for breach or inactivity with notice as required by law.
Changes
We may update these terms at our discretion. Continued use means acceptance of revisions. Review regularly for new policies.
Severability
Invalid provisions are replaced or removed without affecting the rest of this agreement.
Entire Agreement
These terms, plus supplementary policies, represent the full agreement between you and lumivoraquin.sbs.
Contact Us for Queries
Questions about these terms or reporting misuse can be sent via the channels below.
Email address: content@lumivoraquin.sbs
Phone: +27(11)7501627
Address: 155 West Street, Sandton, Johannesburg 2196 South Africa
Effective Date: From December 27, 2025 onward
Version: 1.2